Search

Viatris Inc

Closed

SectorHealthcare

16.93 -1.23

Overview

Share price change

24h

Current

Min

16.91

Max

17.05

Key metrics

By Trading Economics

Income

-295M

-119M

Sales

240M

3.8B

EPS

0.69

Dividend yield

2.91

Profit margin

-3.162

Employees

30,000

EBITDA

9.4M

653M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+10.62% upside

Dividends

By Acuity

Dividend yield

Sector Avg

2.91%

2.27%

Next Earnings

5 Nov 2026

Next Dividend date

14 Dec 2026

Next Ex Dividend date

23 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-1.4B

19B

Previous open

18.16

Previous close

16.93

News Sentiment

By Acuity

100%

0%

314 / 339 Healthcare

Viatris Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Sept 2026, 21:01 UTC

Viatris Inc. is trading modestly higher in after-market hours, currently positioned above its 20-day moving average and near the upper end of its one-month range.

17 Sept 2026, 20:08 UTC

Viatris Inc. shares are up modestly, reaching a peak above the previous close while remaining above the 20-day moving average.

16 Sept 2026, 23:16 UTC

Viatris Inc. is trading modestly lower in after-market hours, having experienced unusual volatility after initially rising earlier in the session.

15 Sept 2026, 20:07 UTC

Viatris shares are roughly flat as the broader market declines amid a significant drop in the NY Empire State Manufacturing Index and rising oil prices.

14 Sept 2026, 20:07 UTC

Viatris Inc's shares are higher today, continuing a gradual increase since Friday's close despite an earlier pullback. No specific news was identified.

11 Sept 2026, 21:41 UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

10 Sept 2026, 20:07 UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

9 Sept 2026, 19:36 UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

8 Sept 2026, 19:46 UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

4 Sept 2026, 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 Sept 2026, 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 Sept 2026, 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 Sept 2026, 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 Aug 2026, 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 Aug 2026, 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 Aug 2026, 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 Aug 2026, 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 Aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 Aug 2026, 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 Aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 Aug 2026, 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 Aug 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 Aug 2026, 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 Aug 2026, 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 Aug 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 Aug 2026, 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 Aug 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 Aug 2026, 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 Aug 2026, 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 Aug 2026, 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

Peer Comparison

Price change

Viatris Inc Forecast

Price Target

By TipRanks

10.62% upside

12 Months Forecast

Average 18.75 USD  10.62%

High 23 USD

Low 13 USD

Based on 8 Wall Street analysts offering 12 month price targets forViatris Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

3

Hold

1

Sell

Sentiment

By Acuity

314 / 339 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.